By: Natalie Tung, M.D. and Gerburg Wulf, M.D., Ph.D. From: wickedlocal.com Most women know the numbers: One in eight will develop invasive breast cancer, and it’s the second most common cancer (next to skin cancer) affecting American women Here’s the good news: Breast cancer death rates have been declining for more than 20 years due to better screening and treatments. …
Study supports cancer link with height
From: bbc.com A Swedish study of five million people appears to support the theory that height and cancer risk are linked. The study found that taller people had a slightly higher risk of breast cancer and skin cancer, among other cancers. Its results found that for every extra 10cm (4in) of height, when fully grown, the risk of developing cancer …
Roche says new drug shows benefits in lung, bladder cancer tests
By: John Miller From: reuters.com Roche ‘s new immune-system boosting cancer drug has given positive results in tests on patients suffering from some lung and bladder cancers, according to data released on Sunday at the European Cancer Congress in Vienna that the company hopes will help it win quick regulatory approval. In its Phase II trial targeting advanced or metastatic …
High-tech mammogram tool doesn’t boost cancer detection, study shows
By: JoNel Aleccia From: seattletimes.com A high-tech tool now used on more than 90 percent of U.S. mammograms doesn’t improve breast-cancer detection and may lead to missed diagnoses — all while adding at least $400 million to the nation’s annual health-care tab, a study by investigators in Boston and Seattle has found. Computer-aided-detection (CAD) for mammography, which aims to double-check …
Almost half of cancer patients struggle to pay their bills, charity warns
By: Charlie Cooper From: independent.co.uk Nearly 400,000 people with a cancer diagnosis in the UK struggle to pay off bills as a result of their condition, the country’s leading cancer care charity has said. The shock findings, based on a survey of more than 2,000 people, found that four in 10 cancer patients are struggling to keep up with financial …
Oncology Leads Development in Promising Gene Therapy Pipeline, says GBI Research
From: gbiresearch.com Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline remains large, with 906 products in active development across all stages. However, the majority of these remain in early steps of development, with 76% at either the Discovery or Preclinical stage, according to business intelligence provider GBI Research. The company’s latest …
FIRST JAPANESE STUDY OF ELECTRON IORT FOR BREAST CANCER YIELDS NO RECURRENCE AT FIVE YEARS
Respected “Radiation Oncology” publication reports on use of electron based intraoperative radiation therapy using the Mobetron® in inaugural study of APBI in Asian countries In the first study of its kind in Japan, an industry leading journal, Radiation Oncology, has reported the results of a 5-year study reviewing electron based IORT as a method of accelerated partial breast irradiation (APBI) …
Research Finds Surgical Marker Helps Cut Cost of Breast Cancer Treatment
3D Device Aids Shorter Radiation Therapy and Improves Cosmetic Outcomes After Surgery Breast cancer research conducted by two Fayetteville medical groups highlights their success in pioneering use of an absorbable, three-dimensional marker used during treatment for breast cancer. Their cost analysis, to be presented at an international breast cancer conference this week, showed that by helping to shorten the course …
Role of cancer-suppressing WWOX gene uncovered
From: theleadsouthaustralia.com.au RESEARCHERS have uncovered the role played by a gene which suppresses the development of cancer. Discovered by scientists at the University of Adelaide in South Australia, the findings on the activity of the gene WWOX open new opportunities for scientists to find treatments for cancer. Professor Rob Richards, Head of Genetics and Evolution in the University’s School of …
TUMOR SUPPRESSOR LRIG1 CONTROLS BREAST CANCER AGGRESSION AND INVASION
From: UC Davis Comprehensive Cancer Center Protein blocks dangerous epithelial-to-mesenchymal transition Researchers at UC Davis have shown that the protein LRIG1 reduces breast cancer invasion and could potentially help control metastasis. Using aggressive basal-like breast cancer cell lines, the scientists found that restoring LRIG1 expression reduced these cells’ growth and invasiveness. The findings provide strong evidence that LRIG1 could be …